The importance of cytomegalovirus-specific antibodies for the prevention of fetal cytomegalovirus infection or disease

Herpes

Volumn 15, Issue 2, 2008, Pages 24-27

  Adler, Stuart P ^a   Nigro, Giovanni ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

CMV antibodies; CMV immunity; Congenital CMV infection; Cytomegalovirus (CMV); Hyperimmune globulin; Passive immunization; Pregnancy

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; HYPERIMMUNE GLOBULIN; MATERNAL ANTIBODY; IMMUNOGLOBULIN;

ANTIBODY TITER; COMPARATIVE STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DRUG MECHANISM; EXPERIMENTAL MODEL; FETUS DISEASE; FIRST TRIMESTER PREGNANCY; HUMAN; INCIDENCE; NONHUMAN; PLACENTA DISORDER; PREGNANCY; PREGNANT WOMAN; PRIMARY INFECTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SECOND TRIMESTER PREGNANCY; ANIMAL; ARTICLE; CYTOMEGALOVIRUS; FEMALE; GUINEA PIG; IMMUNOLOGY; PASSIVE IMMUNIZATION; PREGNANCY COMPLICATION; VERTICAL TRANSMISSION; VIROLOGY;

CAVIA; CYTOMEGALOVIRUS;

ANIMALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FETAL DISEASES; GUINEA PIGS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS, INTRAVENOUS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 73349141413     PISSN: 09697667     EISSN: 14701537     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326: 663-667.
2. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007;17:253-276.
3. Enders G, Bader U, Lindemann L, Schalasta G, Daiminger A. Diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 2001;21: 362-377.
4. Nigro G, Adler SP, La Torre R, Best AM. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005;353: 1350-1362.
5. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 2006;35:216-220.
6. Revello MG, Zavattoni M, Furione M, Fabbri E, Gerna G. Preconceptional primary human cytomegalovirus infection and risk of congenital infection. J Infect Dis 2006;193:783-787.
7. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001;344: 1366-1371.
8. Doyle M, Atkins JT, Rivera-Matos IR. Congenital cytomegalovirus infection in infants infected with human immunodeficiency virus type 1. Pediatr Infect Dis J 1996;15:1102-1106.
9. Chandwani S, Kaul A, Bebenroth D, Kim M, John DD, Fidelia A et al. Cytomegalovirus infection in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J 1996;15:310-314.
10. Lazzarotto T, Spezzacatena P, Varani S, Gabrielli L, Pradelli P, Guerra B et al. Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection. Clin Diagn Lab Immunol 1999;6:127-129.
11. Lanari M, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B et al. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 2006;117:e76-e83.
12. Schleiss MR. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model. J Clin Virol 2008;41:224-230.
13. Bia FJ, Griffith BP, Tarsio M, Hsiung GD. Vaccination for the prevention of maternal and fetal infection with guinea pig cytomegalovirus. J Infect Dis 1980;142: 732-738.
14. Harrison CJ, Britt WJ, Chapman NM, Mullican J, Tracy S. Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model. J Infect Dis 1995;172: 1212-1220.
15. Bourne N, Schleiss MR, Bravo FJ, Bernstein DI. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection. J Infect Dis 2001; 183:59-64.
16. Chatterjee A, Harrison CJ, Britt WJ, Bewtra C. Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs. J Infect Dis 2001;183: 1547-1553.
17. Bratcher DF, Bourne N, Bravo FJ, Schleiss MR, Slaoui M, Myers MG et al. Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs. J Infect Dis 1995;172: 944-950.
18. Yeager AS, Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG. Prevention of transfusion acquired cytomegalovirus infection in newborn infants. J Pediatr 1981;98:281-287.
19. Adler SP, Chandrika T, Lawrence L, Baggett J. Cytomegalovirus infections in neonates acquired by blood transfusions. Pediatr Infect Dis J 1983;2:114-118.
20. Adler SP, Baggett J, Wilson M, Lawrence L, McVoy M. Molecular epidemiology of cytomegalovirus transmission in a nursery: Lack of evidence for nosocomial transmission. J Pediatr 1986;108:117-123.
21. Snydman DR, Werner BG, Meissner HC, Cheeseman SH, Schwab J, Bednarek F et al. Use of cytomegalovirus immunoglobulin in multiple transfused premature neonates. Pediatr Infect Dis J 1995;14:34-40.
22. Nigro G, La Torre R, Anceschi MM, Mazzocco M, Cosmi EV. Hyper - immunoglobulin therapy for a twin fetus with cytomegalovirus infection and growth restriction. Am J Obstet Gynecol 1999; 180:1222-1226.
23. Sissons JG, Carmichael AJ, McKinney N, Sinclair JH, Wills MR. Human cytomegalovirus and immunopathology. Springer Semin Immunopathol 2002;24:169-185.
24. Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR. From infection to autoimmunity. J Autoimmun 2001;16:175-186.
25. Ballow M. Mechanisms of action of intravenous immune serum globulin therapy. Pediatr Infect Dis J 1994;13:806-811.
26. Clark AL, Gall SA. Clinical use of intravenous immunoglobulin in pregnancy. Am J Obstet Gynecol 1997;176:241-253.
27. Keller MA, Stiehm ER. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 2000;13: 602-614.
28. La Torre R, Nigro G, Best AM, Adler SP. Placental enlargement is predictive of a primary maternal cytomegalovirus infection and fetal disease. Clin Infect Dis 2006;43:994-1000.
29. Nigro G, La Torre R, Pentimalli H, Taverna P, Lituania M, Martinez de Tejada B et al. Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenat Diagn 2008; 28:512-517.
30. Schleiss M. The role of the placenta in the pathogenesis of congenital cytomegalovirus infection: is the benefit of cytomegalovirus immune globulin for the newborn mediated through improved placental health and function? Clin Infect Dis 2006;43:1001-1003.
31. Duff P. A thoughtful algorithm for the accurate diagnosis of primary CMV infection in pregnancy. Am J Obstet Gynecol 2007;196:196-197.